{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:36:53Z","timestamp":1772491013164,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007184","name":"Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.yebeh.2019.07.021","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T18:45:05Z","timestamp":1564512305000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PA","title":["Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit"],"prefix":"10.1016","volume":"98","author":[{"given":"Kent A.","family":"Owusu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica B.","family":"Dhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani","family":"McKimmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Cotugno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Sukumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pue","family":"Farooque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina B.","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2019.07.021_bb0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.yebeh.2012.06.016","article-title":"Epilepsy across the spectrum: promoting health and understanding: a summary of the Institute of Medicine report","volume":"25","author":"England","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"31","key":"10.1016\/j.yebeh.2019.07.021_bb0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.15585\/mmwr.mm6631a1","article-title":"National and state estimates of the numbers of adults and children with active epilepsy\u2014United States, 2015","volume":"66","author":"Zack","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.yebeh.2019.07.021_bb0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000053748.83309.28","article-title":"Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoring","volume":"60","author":"Rose","year":"2003","journal-title":"Neurology"},{"issue":"9128","key":"10.1016\/j.yebeh.2019.07.021_bb0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)79574-X","article-title":"Intranasal midazolam for childhood seizures","volume":"352","author":"Lahat","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.yebeh.2019.07.021_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00003088-199936060-00003","article-title":"Pharmacokinetic optimisation of benzodiazepine therapy for acute seizures","volume":"36","author":"Rey","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.yebeh.2019.07.021_bb0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nurt.2009.01.002","article-title":"Intranasal delivery of antiepileptic medications for treatment of seizures","volume":"6","author":"Wermeling","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.yebeh.2019.07.021_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00314967","article-title":"Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration","volume":"41","author":"Rey","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.yebeh.2019.07.021_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0387-7604(00)00155-8","article-title":"Intranasal midazolam for prolonged convulsive seizures","volume":"22","author":"Kutlu","year":"2000","journal-title":"Brain Dev"},{"issue":"12","key":"10.1016\/j.yebeh.2019.07.021_bb0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/088307380001501219","article-title":"Nasal midazolam effects on childhood acute seizures","volume":"15","author":"Fi\u015fgin","year":"2000","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2019.07.021_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2019.07.021_bb0055","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.07.021_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yebeh.2018.09.035","article-title":"Prevalence and predictors of seizure clusters: a prospective observational study of adult patients with epilepsy","volume":"88","author":"Detyniecki","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2019.07.021_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1528-1157.2001.15100.x","article-title":"Antiepileptic drug withdrawal in patients with temporal lobe epilepsy undergoing presurgical video-EEG monitoring","volume":"42","author":"Yen","year":"2001","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2019.07.021_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4065\/84.6.495","article-title":"Safety of long-term video-electroencephalographic monitoring for evaluation of epilepsy","volume":"84","author":"Noe","year":"2009","journal-title":"In Mayo Clin Proc"},{"key":"10.1016\/j.yebeh.2019.07.021_bb0075","unstructured":"Meng TC, Sequeira DJ, Van Ess PJ, Pullman WE. Long-term safety experience of Nayzilam\u2122 (USL261; midazolam nasal spray) in subjects with seizure clusters: safety results from the open-label, phase 3 extension of the ARTEMIS-1 study. Presented at: 72nd Annual Meeting of the American Epilepsy Society; November 30\u2013December 4, 2018; New Orleans, LA. Poster 2, 235."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501930558X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501930558X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:29:36Z","timestamp":1761503376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501930558X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":15,"alternative-id":["S152550501930558X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.07.021","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}